MXC 12.5% 7.0¢ mgc pharmaceuticals ltd

Panax acquisition well advanced,- we are near completion of this key acquisition

  1. 5,069 Posts.
    lightbulb Created with Sketch. 23
    Found this on MXC web site regarding Panax acquition

    Nativ Segev, Co-founder and Managing Director, MGC Pharmaceuticals commented: “ In addition, with the due diligence of our Panax acquisition well advanced, we are near completion of this key acquisition which will substantially enhance the Company’s production and research capabilities and enable licensing into the US.”

    Shouldnt be too far away now
watchlist Created with Sketch. Add MXC (ASX) to my watchlist
(20min delay)
Mkt cap ! $156.0M
Open High Low Value Volume
7.8¢ 7.8¢ 7.0¢ $1.468M 20.31M

Buyers (Bids)

No. Vol. Price($)
10 454510 7.0¢

Sellers (Offers)

Price($) Vol. No.
7.1¢ 950891 5
View Market Depth
Last trade - 16.10pm 04/03/2021 (20 minute delay) ?
-0.010 ( 12.7 %)
Open High Low Volume
7.6¢ 7.7¢ 7.0¢ 13141666
Last updated 15.59pm 04/03/2021 (live) ?
MXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.